MindMeds MM120 Program Receives FDA Breakthrough Therapy Designation for Generalized Anxiety Disorder
MindMed has recently been granted the FDA's "breakthrough therapy" designation for its MM120 program, which is aimed at treating Generalized ...
Tag: CMPS
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Strategic Shift: Kazatomprom Curtails Production and Denies Listing Rumors
